Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Creed

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cerebrovascular Diseases (Basel, Switzerland)|July 22, 2020
Mechanisms of Stroke in COVID-19J David Spence, Gabriel R de Freitas, L Creed Pettigrew, et al.
Stroke|August 14, 2010
Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding studySusan C Fagan, Jennifer L Waller, Fenwick T Nichols, et al.
Alzheimer Disease and Associated Disorders|November 30, 2006
A phase 2 study of tramiprosate for cerebral amyloid angiopathySteven M Greenberg, Jonathan Rosand, Alexander T Schneider, et al.
Stroke|February 14, 2014
C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke studyMitchell S V Elkind, Jorge M Luna, Leslie A McClure, et al.
Stroke|April 5, 2003
Factors influencing outcome and treatment effect in PROACT IILawrence R Wechsler, Robin Roberts, Anthony J Furlan, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cerebrovascular Diseases (Basel, Switzerland)|July 22, 2020
Mechanisms of Stroke in COVID-19J David Spence, Gabriel R de Freitas, L Creed Pettigrew, et al.
Stroke|August 14, 2010
Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding studySusan C Fagan, Jennifer L Waller, Fenwick T Nichols, et al.
Alzheimer Disease and Associated Disorders|November 30, 2006
A phase 2 study of tramiprosate for cerebral amyloid angiopathySteven M Greenberg, Jonathan Rosand, Alexander T Schneider, et al.
Stroke|February 14, 2014
C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke studyMitchell S V Elkind, Jorge M Luna, Leslie A McClure, et al.
Stroke|April 5, 2003
Factors influencing outcome and treatment effect in PROACT IILawrence R Wechsler, Robin Roberts, Anthony J Furlan, et al.
Pageof 4